Pan American Silver Corp. is well-positioned to benefit from sustained high gold and silver prices. Read more on the bullish ...
Amgen is facing a slowdown in uptake of its first-to-market KRAS inhibitor Lumakras as a second-line therapy for KRAS-mutated non-small cell lung cancer (NSCLC), so is understandably excited by new ...
AstraZeneca/Daiichi Sankyo and Gilead Sciences have reported preliminary results of studies that suggest their TROP2-targeted antibody-drug conjugates (ADCs) could have a role to play as a first-line ...
Tottenham have completed the Premier League double over Manchester City nine times so far, more than they have any other opponent. Meanwhile, only Chelsea (10) have done so more a ...
On January 21st 2026, New Age Metals announced the successful acquisition of the Northern Shield PGM-Copper-Nickel Project ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results